SCHEMBL513725

SCHEMBL513725

CC(C)(C)OC(=O)N1CCC(=Cc2cc3ccccc3o2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 1/20 0.48
BACE1 P56817 3/20 0.46
GRM5 P41594 1/20 0.45
GPR119 Q8TDV5 2/20 0.40
ESR2 Q92731 1/20 0.40
ACKR3 P25106 1/20 0.40
NR1H2 P55055 1/20 0.40
CYP2A6 P11509 1/20 0.40
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CKS1B P61024 1/20 0.38
SKP1 P63208 1/20 0.38
SKP2 Q13309 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL512844 0.87 GRM5 (0.44) MMP13GRM5GPR119ESR2NR1H2
SCHEMBL3642719 0.78 GRM5 (0.47) BACE1GRM5GPR119ESR2ACKR3
SCHEMBL1473227 0.76 GPR119 (0.51) GRM5GPR119ESR2NR1H2KDM4E
SCHEMBL6300387 0.76 BACE1 (0.56) MMP13BACE1GPR119HRH4MAPT
SCHEMBL16112794 0.76 GRM5 (0.51) BACE1GRM5GPR119ESR2ACKR3
SCHEMBL512653 0.76 ACKR3 (0.55) MMP13GRM5GPR119ESR2ACKR3
SCHEMBL15594939 0.74 PDK4 (0.53) MMP13GRM5MAPT
SCHEMBL29046359 0.74 RAB9A (0.70) BACE1KDM4EMAPTALDH1A1HPGD
SCHEMBL14749300 0.74 MMP13 (0.48) MMP13BACE1GPR119KDM4EALDH1A1
SCHEMBL7507003 0.74 GRM5 (0.48) BACE1GRM5GPR119KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028931-A1 HETEROCYCLIC M-GLU5 ANTAGONISTS RECORDATI IRELAND LIMITED (IE) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028931-A1 HETEROCYCLIC M-GLU5 ANTAGONISTS OPRM1, GRM5, OPRD1 MMP13 3483/4885BACE1 1951/4885GRM5 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.